CBS News
Suicide deaths reached record high in 2022, but decreased for kids and young adults, CDC data shows
Suicide deaths in the United States reached a record high last year, but decreased among children and young adults, according to provisional data from the Centers for Disease Control and Prevention.
In a report released Wednesday, the organization used death records from the National Center for Health Statistics to estimate that the number of suicides in 2022 was 3% higher than in 2021, totaling 49,449 deaths compared to the previous 48,183.
The report also looked at changes across age, race and sex.
For males, the age-adjusted suicide rate was 1% higher in 2022 than 2021, and it was 4% higher for females. Rates also increased for nearly all racial groups, the report noted.
When it came to age, there were some decreases.
“Suicide rates generally declined for males ages 34 and younger and increased for those 35 and older. For females, rates declined for those ages 24 and younger and increased for those 25 and older,” the report stated.
More specifically, from 2021 to 2022, rates for children aged 10 to 14 declined 18%. There was a 9% decline for those aged 15 to 24 and a 2% drop for those 25 to 34.
The decreases among younger age groups is a hopeful shift after years of concerning increases.
Still, research also shows youth mental health is in crisis more generally, with particularly concerning numbers surrounding teen girls. A CDC survey from earlier this year found around 1 in 3 high school girls in the U.S. have seriously considered attempting suicide and more than half of teen girls, 57%, reported feeling “persistently sad or hopeless.”
Experts believe the overall rise in suicide rates is a result of several factors, including stress, the impact of social media, the COVID-19 pandemic, higher rates of depression, limited access to mental health services and increased access to guns.
If you or someone you know is in emotional distress or a suicidal crisis, you can reach the 988 Suicide & Crisis Lifeline by calling or texting 988. You can also chat with the 988 Suicide & Crisis Lifeline here.
For more information about mental health care resources and support, The National Alliance on Mental Illness (NAMI) HelpLine can be reached Monday through Friday, 10 a.m.–10 p.m. ET, at 1-800-950-NAMI (6264) or email info@nami.org.
-Simrin Singh contributed to this report.
Several hospitals across the U.S. are grappling with shortages of IV fluid after flooding from Hurricane Helene forced medical fluid manufacturers to halt production.
Baxter International, the leading supplier of IV fluids to hospitals, said its facility in Marion, North Carolina, remains closed for the foreseeable future.
“Baxter’s North Cove facility affected by flooding and currently closed for production as the company assesses extent of the impact,” the company says in a statement on its website.
The company, which supplies about 60% of the country’s IV fluid bags, added that it’s working with federal agencies to support recovery efforts and “mitigate supply disruption to patients.”
IV fluids are administered intravenously to treat dehydration and are critical for surgery, during which patients are asleep for a long time and unable to eat and drink.
“Remediation efforts are already underway, and we will spare no resource — human or financial — to resume production and help ensure patients and providers have the products they need,” José (Joe) E. Almeida, chair, president and chief executive officer at Baxter, said in a statement.
Mass General Brigham is among the health care systems that has not received its usual supply of IV fluid. Chief preparedness and continuity officer Dr. Paul Biddinger said during a press conference Friday that the hospital network expects to receive about 40% of what it usually gets from Baxter.
Biddinger called the supply constraint “one of the biggest shortages” the hospital network has ever dealt with.
Other manufacturers of IV fluids say they’re ramping up production to help cover the shortage. B. Braun said none of its manufacturing sites were affected by the Hurricane Helene, and that it’s “taking immediate steps to increase production at our pharmaceutical manufacturing sites in Irvine, California, and Daytona Beach, Florida, focusing on critical IV fluids.”
The company as also placed its products on “protective allocation” and is encouraging providers that administer IVs to practice conservation, including by using alternative hydration methods, a spokesperson told CBS MoneyWatch.
ICU Medical, another IV fluid manufacturer, said it’s also taking steps “to increase production to help meet market needs while continuing to support our existing customers.”
Hospitals also experienced IV fluid shortages in 2017, when Hurricane Maria disrupted manufacturing.
“Having experienced similar challenges in the wake of Hurricane Maria in 2017, we continue to be mindful of how we manage the supply of these medications to ensure minimal impact on our patients. Hospital operations continue as normal and patient care remains unaffected,” Dr. Biddinger of Mass General Brigham said in a statement.
Several hospitals across the U.S. are grappling with shortages of IV fluid after flooding from Hurricane Helene forced medical fluid manufacturers to halt production.
Baxter International, the leading supplier of IV fluids to hospitals, said its facility in Marion, North Carolina, remains closed for the foreseeable future. In a statement on its website, the company says, “Baxter’s North Cove facility affected by flooding and currently closed for production as the company assesses extent of the impact.”
The company, which supplies about 60% of the country’s IV fluid bags, added that it’s working with federal agencies to support recovery efforts and “mitigate supply disruption to patients.”
IV fluids are administered intravenously to treat dehydration and are critical for surgery, during which patients are asleep for a long time and unable to eat and drink.
“Remediation efforts are already underway, and we will spare no resource — human or financial — to resume production and help ensure patients and providers have the products they need,” José (Joe) E. Almeida, chair, president and chief executive officer at Baxter, said in a statement.
Mass General Brigham is among the health care systems that has not received its usual supply of IV fluid. Chief preparedness and continuity officer Dr. Paul Biddinger said during a press conference Friday that the hospital network expects to receive about 40% of what it usually gets from Baxter.
Biddinger called the supply constraint “one of the biggest shortages” the hospital network has ever dealt with.
Other manufacturers of IV fluids say they’re ramping up production to help cover the shortage. B. Braun said none of its manufacturing sites were affected by the Hurricane Helene, and that it’s “taking immediate steps to increase production at our pharmaceutical manufacturing sites in Irvine, California, and Daytona Beach, Florida, focusing on critical IV fluids.”
The company as also placed its products on “protective allocation” and is encouraging providers that administer IVs to practice conservation, including by using alternative hydration methods, a spokesperson told CBS MoneyWatch.
ICU Medical, another IV fluid manufacturer, said it’s also taking steps “to increase production to help meet market needs while continuing to support our existing customers.”
Hospitals also experienced IV fluid shortages in 2017, when Hurricane Maria disrupted manufacturing.
“Having experienced similar challenges in the wake of Hurricane Maria in 2017, we continue to be mindful of how we manage the supply of these medications to ensure minimal impact on our patients. Hospital operations continue as normal and patient care remains unaffected,” Dr. Biddinger of Mass General Brigham said in a statement.
Several hospitals across the U.S. are grappling with shortages of IV fluid after flooding from Hurricane Helene forced medical fluid manufacturers to halt production.
Baxter International, the leading supplier of IV fluids to hospitals, said its facility in Marion, North Carolina, remains closed for the foreseeable future. In a statement on its website, the company says, “Baxter’s North Cove facility affected by flooding and currently closed for production as the company assesses extent of the impact.”
The company, which supplies about 60% of the country’s IV fluid bags, added that it’s working with federal agencies to support recovery efforts and “mitigate supply disruption to patients.”
IV fluids are administered intravenously to treat dehydration and are critical for surgery, during which patients are asleep for a long time and unable to eat and drink.
“Remediation efforts are already underway, and we will spare no resource — human or financial — to resume production and help ensure patients and providers have the products they need,” José (Joe) E. Almeida, chair, president and chief executive officer at Baxter, said in a statement.
Less than half its usual supply
Mass General Brigham is among the health care systems that has not received its usual supply of IV fluid. Chief preparedness and continuity officer Dr. Paul Biddinger said during a press conference Friday that the hospital network expects to receive about 40% of what it usually gets from Baxter.
Biddinger called the supply constraint “one of the biggest shortages” the hospital network has ever dealt with.
Other manufacturers of IV fluids say they’re ramping up production to help cover the shortage. B. Braun said none of its manufacturing sites were affected by the Hurricane Helene, and that it’s “taking immediate steps to increase production at our pharmaceutical manufacturing sites in Irvine, California, and Daytona Beach, Florida, focusing on critical IV fluids.”
The company as also placed its products on “protective allocation” and is encouraging providers that administer IVs to practice conservation, including by using alternative hydration methods, a spokesperson told CBS MoneyWatch.
ICU Medical, another IV fluid manufacturer, said it’s also taking steps “to increase production to help meet market needs while continuing to support our existing customers.”
Hospitals also experienced IV fluid shortages in 2017, when Hurricane Maria disrupted manufacturing.
“Having experienced similar challenges in the wake of Hurricane Maria in 2017, we continue to be mindful of how we manage the supply of these medications to ensure minimal impact on our patients. Hospital operations continue as normal and patient care remains unaffected,” Dr. Biddinger of Mass General Brigham said in a statement.